For TNBC, the formation of ROS, the antioxidant enzyme activity, the copper content, and the Cu/Zn ratio occupied an intermediate position between the values for the luminal A and B(−) subtypes and HER2-positive (luminal B(+) and non-luminal) breast cancer subtypes. The gene discussed is ERBB2; the disease is breast carcinoma.